David Matousek
Nessuna posizione attualmente
Profilo
David Matousek held several positions in various firms.
He was a Director at Kermode Resources Ltd., Director & Head-Investor Relations at Playfair Mining Ltd., Director-Investor Relations at CRH Medical Corp., President at Yankee Hat Minerals Ltd., Head-Corporate Communications & Investor Relations at Eagle Hill Exploration Corp., Senior Manager-Investor Relations & Communications at Zymeworks BC, Inc., and Manager-Investor Relations at Lupaka Gold Corp.
He obtained his undergraduate degree from Simon Fraser University.
Precedenti posizioni note di David Matousek
| Società | Posizione | Fine |
|---|---|---|
Eagle Hill Exploration Corp.
 Eagle Hill Exploration Corp. Other Metals/MineralsNon-Energy Minerals Eagle Hill Exploration Corp. is a mining exploration company, which focuses on exploration and development of the high-grade Windfall Lake Gold Deposit, located between Val-d'Or and Chibougamau in Quebec. The company was founded on July 21, 2006 and is headquartered in Vancouver, Canada. | Contatto Relazioni con gli Investitori | 14/08/2013 |
Yankee Hat Minerals Ltd.
 Yankee Hat Minerals Ltd. Other Metals/MineralsNon-Energy Minerals Yankee Hat Minerals Ltd. was a mineral exploration company, which engaged in the acquisition, exploration and development of precious metal properties. The company was founded on October 22, 1993 and was headquartered in Vancouver, Canada. | Presidente | 01/11/2012 |
Zymeworks BC, Inc.
 Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Contatto Relazioni con gli Investitori | - |
| CRH MEDICAL CORPORATION | Contatto Relazioni con gli Investitori | - |
| LUPAKA GOLD CORP. | Contatto Relazioni con gli Investitori | - |
Formazione di David Matousek
| Simon Fraser University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| PLAYFAIR MINING LTD. | Non-Energy Minerals |
| KERMODE RESOURCES LTD. | Non-Energy Minerals |
| LUPAKA GOLD CORP. | Non-Energy Minerals |
| Aziende private | 4 |
|---|---|
Yankee Hat Minerals Ltd.
Yankee Hat Minerals Ltd. Other Metals/MineralsNon-Energy Minerals Yankee Hat Minerals Ltd. was a mineral exploration company, which engaged in the acquisition, exploration and development of precious metal properties. The company was founded on October 22, 1993 and was headquartered in Vancouver, Canada. | Non-Energy Minerals |
Eagle Hill Exploration Corp.
Eagle Hill Exploration Corp. Other Metals/MineralsNon-Energy Minerals Eagle Hill Exploration Corp. is a mining exploration company, which focuses on exploration and development of the high-grade Windfall Lake Gold Deposit, located between Val-d'Or and Chibougamau in Quebec. The company was founded on July 21, 2006 and is headquartered in Vancouver, Canada. | Non-Energy Minerals |
CRH Medical Corp.
 CRH Medical Corp. Medical/Nursing ServicesHealth Services CRH Medical Corp. engages in the provision of gastroenterologists with services and products for the treatment of gastrointestinal diseases. It operates through the following business segments: Anesthesia Services, Product Sales, and Other. It also offers the CRH O'Regan System, which focuses on physician education, patient outcomes, and patient awareness. The Other segment covers the corporate activities. The company was founded in 2000 and is headquartered in Vancouver, Canada. | Health Services |
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Health Technology |
- Borsa valori
- Insiders
- David Matousek
